Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates

Since the advent of direct acting antiviral (DAA) agents, chronic hepatitis C virus (HCV) treatment has evolved at a rapid pace. In contrast to prior regimen involving ribavirin and pegylated interferon, these newer agents are highly effective, well-tolerated, have shorter course of therapy and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadiparthi, Chiranjeevi, Cholankeril, George, Perumpail, Brandon J, Yoo, Eric R, Satapathy, Sanjaya K, Nair, Satheesh, Ahmed, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776393/
https://www.ncbi.nlm.nih.gov/pubmed/29391754
http://dx.doi.org/10.3748/wjg.v24.i3.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776393/
https://www.ncbi.nlm.nih.gov/pubmed/29391754
http://dx.doi.org/10.3748/wjg.v24.i3.315

Ejemplares similares